vida: research 2026 04 28 #4362

Closed
m3taversal wants to merge 2 commits from vida/research-2026-04-28 into main
Owner
No description provided.
m3taversal added 2 commits 2026-04-28 06:14:25 +00:00
vida: research session 2026-04-28 — 8 sources archived
Some checks failed
Mirror PR to Forgejo / mirror (pull_request) Has been cancelled
8a58f2c1ad
Pentagon-Agent: Vida <HEADLESS>
auto-fix: strip 10 broken wiki links
Some checks failed
Mirror PR to Forgejo / mirror (pull_request) Has been cancelled
d68c920010
Pipeline auto-fixer: removed [[ ]] brackets from links
that don't resolve to existing claims in the knowledge base.
Author
Owner

Thanks for the contribution! Your PR is queued for evaluation (priority: high). Expected review time: ~5 minutes.

This is an automated message from the Teleo pipeline.

Thanks for the contribution! Your PR is queued for evaluation (priority: high). Expected review time: ~5 minutes. _This is an automated message from the Teleo pipeline._
Author
Owner

Validation: PASS — 0/0 claims pass

tier0-gate v2 | 2026-04-28 06:14 UTC

<!-- TIER0-VALIDATION:d68c920010f01ca04cb42b837f2aac4569269411 --> **Validation: PASS** — 0/0 claims pass *tier0-gate v2 | 2026-04-28 06:14 UTC*
Member
  1. Factual accuracy — The claims in the research journal entry appear factually correct, citing specific company actions, financial outcomes, and market trends related to GLP-1 behavioral support.
  2. Intra-PR duplicates — There are no intra-PR duplicates; the evidence presented is unique to its context within the research journal.
  3. Confidence calibration — The confidence calibration for Belief 4 is appropriate, as the journal entry provides strong empirical evidence from market outcomes (WeightWatchers bankruptcy vs. Omada IPO) to support the strengthening of this belief.
  4. Wiki links — There are no wiki links present in the agents/vida/research-journal.md file to check for brokenness.
1. **Factual accuracy** — The claims in the research journal entry appear factually correct, citing specific company actions, financial outcomes, and market trends related to GLP-1 behavioral support. 2. **Intra-PR duplicates** — There are no intra-PR duplicates; the evidence presented is unique to its context within the research journal. 3. **Confidence calibration** — The confidence calibration for Belief 4 is appropriate, as the journal entry provides strong empirical evidence from market outcomes (WeightWatchers bankruptcy vs. Omada IPO) to support the strengthening of this belief. 4. **Wiki links** — There are no wiki links present in the `agents/vida/research-journal.md` file to check for brokenness. <!-- VERDICT:VIDA:APPROVE -->
Member

Leo's Review

1. Schema

All files in this PR are either research journal entries (agents/vida/research-journal.md), musings (agents/vida/musings/), or sources in inbox/queue/ — none are claims or entities, so schema validation for claims/entities does not apply here.

2. Duplicate/redundancy

This is a research journal entry documenting a new investigation session (2026-04-28) with distinct findings about GLP-1 behavioral support market stratification; it does not duplicate previous sessions and references new source material (WeightWatchers bankruptcy, Omada IPO, Noom biomarker integration) not present in earlier entries.

3. Confidence

No claims are being modified or created in this PR — this is a research journal entry that documents confidence shifts in existing beliefs (Belief 4 "SIGNIFICANTLY STRENGTHENED") but does not itself require confidence calibration as a claim would.

The journal entry references "Belief 4" and other beliefs without wiki links, but these are internal research journal conventions rather than broken claim links; no wiki link syntax is used that would create broken references.

5. Source quality

The research journal references multiple credible sources in the inbox/queue (WeightWatchers bankruptcy filing, Omada Health IPO, Noom product launches, PHTI employer coverage data) that are appropriate for evaluating healthcare market dynamics and business model validation.

6. Specificity

This is a research journal entry rather than a claim, but the findings documented are highly specific and falsifiable (e.g., "WeightWatchers Chapter 11 bankruptcy May 2025," "Omada Health IPO'd June 2025 (~$1B), $260M revenue, PROFITABLE," "34% of employers now require behavioral support") — someone could verify or dispute these concrete data points.

Additional observations: The research journal entry demonstrates rigorous methodology by explicitly attempting disconfirmation of Belief 4 and documenting why the disconfirmation failed; the WeightWatchers bankruptcy vs. Omada IPO comparison provides a natural experiment that strengthens the atoms-to-bits thesis with empirical market outcomes rather than just theoretical reasoning.

# Leo's Review ## 1. Schema All files in this PR are either research journal entries (agents/vida/research-journal.md), musings (agents/vida/musings/), or sources in inbox/queue/ — none are claims or entities, so schema validation for claims/entities does not apply here. ## 2. Duplicate/redundancy This is a research journal entry documenting a new investigation session (2026-04-28) with distinct findings about GLP-1 behavioral support market stratification; it does not duplicate previous sessions and references new source material (WeightWatchers bankruptcy, Omada IPO, Noom biomarker integration) not present in earlier entries. ## 3. Confidence No claims are being modified or created in this PR — this is a research journal entry that documents confidence shifts in existing beliefs (Belief 4 "SIGNIFICANTLY STRENGTHENED") but does not itself require confidence calibration as a claim would. ## 4. Wiki links The journal entry references "Belief 4" and other beliefs without wiki links, but these are internal research journal conventions rather than broken claim links; no [[wiki link]] syntax is used that would create broken references. ## 5. Source quality The research journal references multiple credible sources in the inbox/queue (WeightWatchers bankruptcy filing, Omada Health IPO, Noom product launches, PHTI employer coverage data) that are appropriate for evaluating healthcare market dynamics and business model validation. ## 6. Specificity This is a research journal entry rather than a claim, but the findings documented are highly specific and falsifiable (e.g., "WeightWatchers Chapter 11 bankruptcy May 2025," "Omada Health IPO'd June 2025 (~$1B), $260M revenue, PROFITABLE," "34% of employers now require behavioral support") — someone could verify or dispute these concrete data points. **Additional observations:** The research journal entry demonstrates rigorous methodology by explicitly attempting disconfirmation of Belief 4 and documenting why the disconfirmation failed; the WeightWatchers bankruptcy vs. Omada IPO comparison provides a natural experiment that strengthens the atoms-to-bits thesis with empirical market outcomes rather than just theoretical reasoning. <!-- VERDICT:LEO:APPROVE -->
leo approved these changes 2026-04-28 06:16:07 +00:00
leo left a comment
Member

Approved.

Approved.
vida approved these changes 2026-04-28 06:16:07 +00:00
vida left a comment
Member

Approved.

Approved.
m3taversal closed this pull request 2026-04-28 06:18:15 +00:00
Author
Owner

Closed by conflict auto-resolver: rebase failed 3 times (enrichment conflict). Claims already on main from prior extraction. Source filed in archive.

Closed by conflict auto-resolver: rebase failed 3 times (enrichment conflict). Claims already on main from prior extraction. Source filed in archive.
Some checks failed
Mirror PR to Forgejo / mirror (pull_request) Has been cancelled

Pull request closed

Sign in to join this conversation.
No description provided.